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ABSTRACT 
Background/Aims: In Japan, aphthous-type Crohn’s disease (type A CD) is thought to 
represent an early phase of Crohn’s disease (CD), and diagnosis of type A CD is possible in the 
diagnostic criteria for CD in Japan. However, the details of type A CD are not well understood. 
Methods: Subjects comprised 649 CD patients diagnosed between 1985 and 2011. The 
incidence of type A CD over time was clarified in two periods (1985-2004 and 2005-2011). The 
course of type A CD was also investigated, and cases that did and did not progress to typical 
CD were compared. Results: No significant difference was seen in the incidence of type A CD 
between the two periods (5.2% vs. 8.5%, p=0.125). Type A CD patients followed at our 
hospital progressed to typical CD at a rate of 59.3%. In comparing progressive and 
non-progressive cases, the frequency of large, densely distributed aphthous lesions in the small 
intestine was higher among progressive cases (p=0.018). Conclusion: Type A CD is an early 
phase of CD, and CD diagnostic criteria including early cases are valid in Japan. 
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INTRODUCTION 
Crohn’s disease (CD) is a granulomatous inflammatory disease of unknown cause that occurs 
mainly in young people. Aphthous lesions are often seen in CD accompanying typical findings 
of longitudinal ulcers or cobblestone appearance, but a form of CD comprising aphthous 
lesions only also exists. We have named this type of CD as aphthous-type CD (type A CD), and 
it appears to represent an early phase of CD [1-7]. Several reports have described the 
progression of type A CD to typical CD [3-5,7], but details such as the incidence, clinical 
characteristics, course, and differences between cases that progress to typical CD and those that 
do not remain unclear. Type A CD is diagnosed in the stage of early lesions only, and a more 
detailed understanding is important for clarifying the natural history of CD. The aim of this 
study was to elucidate the incidence, clinical characteristics, and course of type A CD, as well 
as differences between progressive and non-progressive cases. The validity of the diagnostic 
criteria in Japan is also discussed. 
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METHODS 
In the diagnostic criteria for CD in Japan (Table 1) [8], a definitive diagnosis of CD is possible 
even with aphthous lesions only if non-caseating epithelioid cell granuloma is seen 
histopathologically. Using the CD diagnostic criteria in Japan, type A CD was defined in the 
present investigation as disease meeting the criteria of major finding C (non-caseating 
epithelioid cell granuloma) of the diagnostic criteria plus secondary finding 2a (multiple small 
aphthous ulcerations with longitudinal arrangement) or 2b (multiple small aphthous ulcerations 
in both upper and lower digestive tract). 
Subjects were 649 CD patients diagnosed between 1985 and 2011 in the department of 
gastroenterology at Fukuoka University Chikushi Hospital. The incidence of type A CD with 
respect to all CD diagnosed in the two time periods of 1985-2004 (first-term diagnosis group) 
and 2005-2011 (second-term diagnosis group) was determined with the aim of ascertaining the 
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incidence of type A CD over time. The reason why we have divided cases into these two 
periods was that 22 patients with type A CD from before 1985 until 2004 were summarized in a 
report by Hirai et al. [9].   
In addition, clinical characteristics and course of type A CD, and characteristics of cases that 
progressed to typical CD (progressive group) and cases that had not progressed as of the end of 
the investigation (non-progressive group) were studied. 
Furthermore, the course of cases of aphthous colitis without granuloma who did not meet the 
diagnostic criteria for CD was also analyzed separately. 
 
X-ray and endoscopy methods 
Aphthous lesions were defined as barium flecks <10 mm in diameter with or without 
surrounding radiolucency and as erythematous mucosal plaques with central depression on 
endoscopy. Aphthous lesions were defined as small if the barium flecks were <2 mm in 
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diameter and large if they were ≥2 mm. In cases when endoscopic examination only was done 
without X-ray examinations, endoscopic findings were applied to the above classifications. 
Aphthous lesions were defined as dense if there were ≥6 aphthous lesions within about 3 cm, 
and scattered if there were <6 lesions. With regard to severity, cases defined as having small or 
scattered lesions were placed in a mild group (Figs. 1-a, b), while those defined as having large 
and dense lesions were placed in a severe group (Figs. 2-a, b). The severity of colonic lesions in 
patients who have aphthous lesions only in the small intestine was classified as mild, and the 
severity of small intestinal lesions in patients who have aphthous lesions only in the colon was 
classified as mild in this study. All cases were classified into the two groups separately 
depending on lesions of the small and large intestine (Table 2).  In both X-ray and endoscopic 
examinations, severity was evaluated at the site of maximum lesion severity. Progression to 
typical CD was defined as when the typical lesions of longitudinal lesions or cobblestone 
appearance were seen in either the small or large intestine. 
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Statistical analysis 
An unpaired t-test was used in comparing mean values between groups, and the 2 test or 
Fisher’s exact test was used for comparisons of incidence. The Kaplan-Meier method was used 
for the respective cumulative progression rates, and the Wilcoxon test was used for 
between-group comparisons. 
 
RESULTS 
Incidence of type A CD over time 
Among all 649 subjects, 41 (6.3%) had type A CD. Among the 426 subjects in the first-term 
diagnosis group, 22 (5.2%) had type A CD. Among the 223 subjects in the second-term 
diagnosis group, 19 (8.5%) had type A CD. No significant differences were seen in the 
incidence of type A CD between the first- and second-term diagnosis groups (5.2% vs. 8.5%, 
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respectively; p=0.125) (Fig.3). 
 
Clinical characteristics, course, and comparison of progressive and non-progressive cases 
of type A CD 
A full-range X-ray or endoscopic search of the small and large intestines was performed at the 
time of diagnosis in 41 type A CD patients. Biopsies were taken at several sites and 
non-caseating epithelioid cell granuloma was detected in at least one location. 
The male-female ratio in these 41 patients was 28:13, mean age at onset was 22.2±10.1 years, 
and mean age at diagnosis was 22.8±8.4 years. The mean clinical observation period was 
96.9±89.2 months, and the mean observation period for imaging tests was 55.5±75.7 months. 
Initial blood test findings were hemoglobin (Hb) 13.0±1.55 g/dL, albumin (Alb) 4.0±0.38 g/dL, 
C-reactive protein (CRP) 1.9±3.4 mg/dL, and Crohn’s disease activity index (CDAI) 
111.5±65.5. Anal lesions were seen at the time of initial examination in 13 patients (48.1%). 
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Of the 41 patients, images of the course of gastrointestinal lesions could be observed for 24 
months in 27 patients. Aphthous lesions in the small intestine were seen in 25 of 27 patients 
(92.6%). Aphthous lesions in the large intestine were seen in 23 patients (85.2%). Of these 27 
patients, typical lesions appeared in the small or large intestine and the case progressed to 
typical CD in 16 patients (59.3%). The cumulative rate of progression to typical CD is shown 
in Figure 4. The mean image observation period until the appearance of typical lesions in 
progressive cases was 41.4±31.4 months. Progression to typical CD occurred in 9 of the 16 
patients (56.3%) within 36 months, and in 14 patients (87.5%) within 60 months. Only 2 cases 
progressed to typical CD after a course of more than 60 months. The cumulative progression 
rate to typical CD was 85.1% at 230 months. Among the 16 patients that progressed to typical 
cases, typical lesions appeared in the small intestine and aphthous lesions disappeared or 
remained unchanged in the large intestine in 8 patients; in other words, the clinical entity in 
these patients changed to ileal CD (Figs. 5-a,b). Conversely, progression to typical lesions in 
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the large intestine only and a change in the clinical entity to colonic CD was seen in 4 patients 
(Figs. 6-a,b). A change to ileo-colic CD, in which typical lesions appeared first in the small 
intestine and then appeared later in the large intestine also, occurred in 4 patients. 
Among 11 non-progressive cases, aphthous lesions were seen in the small intestine at the 
time of diagnosis in all 11 patients. These aphthous lesions disappeared and did not recur 
during observation in 5 patients, recurred in 1 patient, and did not show significant changes in 5 
patients. Aphthous lesions were seen in the large intestine at the time of diagnosis in 10 of the 
11 non-progressive cases. Aphthous lesions in the large intestine disappeared and did not recur 
later in 4 patients, recurred in 4 patients, and did not show significant changes in 2 patients. 
Non progressive cases needed fewer hospitalizations (0.4±0.9) than progressive cases needed 
(4.6±4.4). Non progressive cases underwent no surgery (0%) , in contrast, progressive cases 
underwent surgery much more frequently (31.3%) . No patients progressed to UC during the 
due course. 
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In a comparison of progressive and non-progressive groups, no significant differences were 
seen between the groups in the male-female ratio, age at onset, age at diagnosis, initial test 
findings (Hb, Alb, CRP), CDAI at initial examination, or incidence of anal lesions at the initial 
examination. With regard to the severity of aphthous lesions in the small intestine, the 
frequency of severe cases was significantly higher in progressive groups (9/16) than in 
non-progressive groups (1/11, p=0.018). No significant difference was seen between 
progressive and non-progressive groups in terms of the severity of aphthous lesions in the large 
intestine (Table 3). Among those patients who underwent both endoscopic and X-ray 
examinations, no cases showed differing severity of aphthous lesions between these 
investigations. There were no significant differences in initial or maintenance therapies in this 
study between the progressive and non-progressive groups (Table 4).  
A search of aphthous colitis patients without granuloma revealed 5 such patients had been 
treated at our hospital to date in these 26 years. In these 5 patients, 2 or more examinations 
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were performed with an interval of at least 2 years, and biopsies were taken to confirm the 
persistent absence of granuloma and all 5 patients did not progress to typical CD.  
 
DISCUSSION 
The incidence of type A CD among all CD differs depending on the institution in Japan, but 
reports from leading specialty institutions indicates that the proportion is about 5-10% of all 
CD [4,5,7]. No reports appear to have described this incidence in other countries. In the present 
study, the incidence of type A CD was about the same as in previous studies. However, no 
previous investigations have reported rates of patients diagnosed with type A CD over time, as 
in this study. 
The male-female ratio of the 41 type A CD patients in this study included more males, and 
mean age at the time of diagnosis was 22.8±8.4 years. This did not differ greatly from the 
characteristics of typical CD as reported in a national survey in Japan by Asakura et al. [10]. In 
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blood test findings, Hb and Alb values were maintained fairly well, while CRP appeared mildly 
elevated. CDAI was low. Anal lesions were seen in 48.1%, this frequency of anal lesions was 
comparable to the rate of anal lesions in typical CD reported in Japan by Yano et al. [11].  
Typical lesions appeared during the course in 59.3% of cases, and while the observation period 
and numbers of patients differed, this was about the same as incidences reported elsewhere 
(44-80%) [4,5,7]. 
The mean time until typical lesions appeared was 41 months, and 14 patients (88%) progressed 
to typical CD within 60 months. Only 2 cases progressed to typical CD after a course of more 
than 5 years and, from the present results at least, cases in which progression was not seen at 5 
years after diagnosis were presumed to be unlikely to progress subsequently. Therefore, the 
time needed to judge whether type A CD will progress to typical CD is thought to be about 5 
years from diagnosis. The course during this period needs to be observed using modalities such 
as radiography or endoscopic examinations. 
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Type A CD was found to progress to typical CD at a regular rate. In our hospital, 5 patients 
with aphthous colitis and no granuloma have been treated to date, and all 5 patients did not 
progress to typical CD. This suggests that type A CD is an early phase of CD. In addition, the 
validity of the ability to diagnose type A CD using the diagnostic criteria for CD in Japan is 
thought to have been demonstrated. 
In the 16 patients with progressive disease, the final disease type was ileal CD in 8 patients 
(50%), ileo-colic CD in 4 patients (25%), and colonic CD in 4 patients (25%). These 
proportions were similar to the proportions of CD type in Japan reported by Yano et al. [11]. 
Moreover, intestinal lesions at the time of progression from type A CD were similar to the 
lesions seen in morphologically typical CD. Thus, typical CD that has progressed through type 
A CD is not considered special in terms of either type frequency or morphology compared with 
CD reported to date. 
Cases with no progression were also seen among the type A CD cases that were followed. 
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This was seen in about 40% of cases, but the relatively high remission maintenance is 
consistent with the natural history of CD [12, 13]. Previous analyses of the natural history of 
CD have indicated the existence of a group with a good course in CD. Veloso et al. [12] 
analyzed the course of 480 patients observed for an average of 7.2 years, and reported a 
remission rate of 40% in every year except for the year of diagnosis. Beaugerie et al. [13] 
investigated 1,188 cases and reported that the rate of non-disabling disease was 19.4% in the 
study population. That not all cases of CD reached the stage of disabling disease in these 
studies is consistent with the finding of non-progressive cases among type A CD patients in the 
present study. 
The severity of aphthous lesions was analyzed, and the severity of aphthous lesions in the 
small intestine was suggested to contribute to subsequent progression. This is similar to the 
form of early postoperative recurrence [14]. Rutgeerts et al. [15] reported a trend for poorer 
prognosis with the appearance of aphthae with greater severity in the postoperative neoterminal 
 18 
 
ileum. Patients in the present investigation had initial type A CD rather than being 
postoperative patients, but, interestingly, both this study and that by Rutgeerts et al. [15] found 
that the severity of small intestine lesions contributed to later progress. 
No consensus has been reached regarding whether type A CD should be treated, and if so, what 
kind of treatment should be used. There were no significant differences in initial or 
maintenance therapies in this study between the progressive and non-progressive groups. So we 
concluded that any treatments have not affected significantly the course of type A CD. In the 
future, more detailed investigations are needed to identify patients who do not require treatment 
and to establish appropriate treatment regiments. 
The limitations of the present study include the retrospective cohort study design, the 
difficulty of diagnosing type A CD beyond institutions that can coordinate with an expert 
pathologist, the potentially inadequate number of patients and observation period, and the fact 
that detailed radiographic examinations are possible only at special institutions. In addition, 
 19 
 
while all 27 type A CD patients who could be followed underwent small bowel radiography and 
large bowel endoscopy, and not all patients underwent small bowel endoscopy or barium enema. 
However, the present study was highly meaningful in that the incidence of type A CD over time 
was found to be almost constant, clinical characteristics and course were clarified, and 
comparison of progressive and non-progressive cases was undertaken. 
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FIGURE LEGENDS 
Figure 1. Mild group aphthous lesions in small bowel radiography. Dense, small aphthae are 
seen in the ileum (a). Mild group aphthous lesions in large bowel endoscopy. Scattered, small 
aphthae are seen in the large intestine (b). 
 
Figure 2. Severe group aphthous lesions in small bowel radiography. Dense, large aphthae are 
seen in the ileum (a). Severe group aphthous lesions in large bowel endoscopy. Dense, large 
aphthae are seen in the large intestine (b). 
 
Figure 3. Frequency of each disease type at each term of CD. No marked changes in the 
frequency of each disease type are seen in the two terms. Numbers in the graph indicate the 
frequency (percentage) of each disease type at each term. 
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Figure 4. Cumulative progression rate of aphthous type CD (n=27) using the Kaplan-Meier 
method. Mean observation period: 84 ± 80 months. 
 
Figure 5. In the first small bowel radiography, dense and large aphthae are present in the ileum 
(a). In follow-up small bowel radiography, longitudinal ulcers together with convergence of 
mucous folds are seen at the same site (b). 
 
Figure 6. In the first large bowel endoscopy, dense and large aphthae are present in the sigmoid 
colon (a). In follow-up endoscopy, longitudinal ulcers are seen at the same site (b). 
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Table 1. Diagnostic criteria for Crohn's disease (1995) 
1. Major findings 
A) Intestinal longitudinal ulcer 
B) Cobblestone appearance 
C) Noncaseating epithelioid cell granuloma 
2. Secondary findings 
a) Multiple small aphthous ulcerations with longitudinal arrangement 
b) Multiple small aphthous ulcerations in both upper and 
    lower digestive tract 
3. Definite diagnosis： 
1) Presence of major finding A or B 
2) Presence of major finding C and one secondary finding 
4. Suspected diagnosis： 
1) Presence of one secondary finding 
3) Presence of major finding A or B without differential  
     diagnosis from ischemic enterocolitis or ulcerative colitis 
2) Presence of major finding C only 
Table 2. Definitions for ｓeverity of aphthous lesions 
Small 
<2 mm 
 
      
Large 
≥2 mm 
           
mild 
mild 
mild 
severe 
Scattered 
<6 lesions/3-cm segment 
Dense 
 ≥6 lesions/3-cm segment 
Table 3.  Comparison of initial findings in patients with type A CD  
who progressed and who did not progress  
Progressive group 
(n=16) 
Nonprogressive group 
(n=11) 
Male:female 
Mean age at onset (years)  
Test findings 
Alb, g/dL 
CRP, mg/dL 
CDAI  
 13:3 8:3 
3.9±0.4 
3.0±4.9 
112.3±71.6 
13.1±1.6 
4.0±0.3 
113.4±92.1 
Hb, g/dL  
22.3±12.8 
13.2±1.5 
20.6±7.7 
1.3±1.8 
0.66 
0.72 
0.97 
0.35 
0.28 
0.97 
Mean age at diagnosis (years)  0.62 23.4±12.7 21.3±7.8 
p 
Activity 
Aphthous lesions,  severe /none or mild 
Small intestine 
9/7 1/10 0.018 
7/9 3/8 0.45 Large intestine 
Perianal lesions 8/8 5/6 1 
Table 4.  Comparison of treatments before progression in patients with type A CD   
who progressed and who did not progress 
Progressive group 
(n=16) 
Nonprogressive group 
(n=11) 
 Elemental diet,  ≥ 600 kcal/day 
0.35 
1 
1 
0.18 
p 
5-amino salicylid acid 0.22 
Total Parenteral Nutrition 
Prednisolone 
5/11 
6/10 
3/13 
1/15 
4/12 
1/10 
1/10 
2/9 
1/10 
6/5 
Initial treatment 
Maintenance treatment 
 Elemental diet,  ≥ 600 kcal/day 0.68 4/12 4/7 
0.13 Biologic 1/15 4/7 
Immunomodulators 0.16 0/16 2/9 
5-amino salicylid acid 0.70 7/9 6/5 
Biologic 
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